Athersys Awarded $3.6 Million in Grant Funding For Stem Cell Product Development: http://t.co/bkQAMsRf
posted 2 days ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA), a leading molecular diagnostics company, today announced that its Annual General Shareholders' Meeting (AGM) held on 28 May, 2010, approved the appointment of Ms. Hilde Windels, Mr. Edward L. Erickson, and Mr. Mark Myslinski to the Board of Directors, as well as all other agenda items of the AGM. The appointment of the new directors is effective immediately for a period until the 2013 AGM. read more
OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading molecular diagnostics company, announced today that its Belgium based clinical diagnostics service laboratory has received the important ISO 9001:2008 certification from Lloyds Register Quality Assurance Ltd. read more
Onderzoekers van het Instituut voor Tropische Geneeskunde ontdekten bij toeval dat de slaapziekteparasiet niet alleen zo lastig te bestrijden is omdat hij zich in de hersenen verschuilt - wat we al langer wisten - maar ook in testikels. De ontdekking kwam er nadat de vorsers er in geslaagd waren om een lichtgevende versie van de slaapziekteparasiet te kweken. read more
Ablynx [Euronext Brussels: ABLX] today announced that Boehringer Ingelheim has selected a Nanobody lead candidate for further development for the treatment of Alzheimer's disease. This is the first lead candidate emerging from the Alzheimer's disease collaboration between Ablynx and Boehringer Ingelheim, and will result in a €2 million milestone payment to Ablynx. read more
